Wealthspire Advisors (New York)’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,115
Closed -$285K 1011
2025
Q4
$285K Buy
1,115
+963
+634% +$252K ﹤0.01% 817
2025
Q3
$39.7K Buy
+152
New +$40K ﹤0.01% 1338
2023
Q4
Sell
-420
Closed -$204K 650
2023
Q3
$204K Buy
+420
New +$197K ﹤0.01% 559
2023
Q2
Sell
-454
Closed -$220K 566
2023
Q1
$220K Sell
454
-354
-44% -$175K ﹤0.01% 490
2022
Q4
$414K Buy
+808
New +$425K 0.01% 403
2021
Q2
Sell
-1,484
Closed -$622K 504
2021
Q1
$622K Buy
1,484
+210
+16% +$83.8K 0.01% 340
2020
Q4
$523K Buy
1,274
+373
+41% +$155K 0.02% 298
2020
Q3
$373K Sell
901
-3
-0.3% -$1.21K 0.02% 210
2020
Q2
$351K Sell
904
-328
-27% -$123K 0.02% 187
2020
Q1
$387K Buy
+1,232
New +$416K 0.02% 335
2019
Q1
Sell
-163
Closed -$47K 383
2018
Q4
$47K Buy
+163
New +$51.7K ﹤0.01% 193

Other funds holding HUM

Wealthspire Advisors (New York)'s HUM Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of Humana (HUM) in Q1 2026, closing a stake of 1,115 shares — an estimated $285K sold.

Wealthspire Advisors (New York) first reported a position in HUM in Q4 2018 and held it in 11 quarters. The position peaked at $622K in Q1 2021. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,115 Humana shares in Q1 2026, an estimated $285K.
  • Wealthspire Advisors (New York) first reported a position in Humana in Q4 2018 and held it in 11 quarters.
  • Wealthspire Advisors (New York)'s Humana position peaked at $622K in Q1 2021.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.